Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.35 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 3/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | TYR | P14679 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28994848 | 0.87 | BACE1 (0.38) | BACE1MAPTKDM4EHTTCA12 | |
| SCHEMBL12909500 | 0.81 | LMNA (0.44) | BACE1ELANEMAPTPOLBKMT2A | |
| SCHEMBL18613360 | 0.80 | KMT2A (0.49) | BACE1ELANEMAPTKMT2AMEN1 | |
| SCHEMBL28711315 | 0.80 | ELANE (0.41) | BACE1ELANEKMT2AMEN1NPC1 | |
| SCHEMBL22289510 | 0.78 | HCAR2 (0.51) | MAPTKDM4EPOLBTHRBKMT2A | |
| SCHEMBL24844759 | 0.78 | BACE1 (0.40) | BACE1MAPTKDM4EKMT2AMEN1 | |
| SCHEMBL14870985 | 0.78 | ELANE (0.47) | BACE1ELANEBTN3A1 | |
| SCHEMBL1206536 | 0.78 | BACE1 (0.45) | BACE1MAPTKDM4EKMT2AMEN1 | |
| SCHEMBL16610054 | 0.77 | SMN1; SMN2 (0.51) | MAPTKDM4EPOLBKMT2AMEN1 | |
| SCHEMBL9124514 | 0.77 | PTGS2 (0.45) | MAPTKDM4EPOLBKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260041661-A1 | THREE-COMPONENT PRODRUG, PHARMACEUTICAL COMPOSITION THEREOF, AND MEDICAL USE THEREOF | J2H BIOTECH INC. (KR) | 2026-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260041661-A1 | THREE-COMPONENT PRODRUG, PHARMACEUTICAL COMPOSITION THEREOF, AND MEDICAL USE THEREOF | FPGS, TFB2M, UFM1 | BACE1 55/4885ELANE 3471/4885MAPT 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.